Rapid switching from levetiracetam to brivaracetam in pharmaco-resistant epilepsy in people with and without intellectual disabilities: a naturalistic case control study.
L V WatkinsH DunstallC MusichaC LawthomK JohnC BrightC RichingsK HardingS MoonS E PapeR WinterhalderV AllgarR H ThomasB McLeanR LaugharneRichard LaugharnePublished in: Journal of neurology (2023)
Switching from LEV to BRV appears as well tolerated and efficacious in PwID as those without ID with over 90% still on BRV after 12 months.
Keyphrases